SYN1 and Alzheimer disease: Pharmacological activation of LXR results in significant hypomethylation and restoration of synapse related genes, including synapsin-1, synaptophysin, and synapse- associated protein 102 (SAP-102), in the hippocampus of triple-transgenic AD (3xTg-AD) mice [17].